Companies›Industrials›Capital Goods›Aerospace & Defense
NSE:JAYKAY

JAYKAY ENTERPRISES LTD

Capital Goods › Aerospace & Defense
₹201.40
at close · 28 Oct 2026
▲ 1.30 (+0.65%)
ThemesArtificial Intelligence· growing

Latest filings

  1. Subsidiary gets CDSCO licence to manufacture orthopaedic and spinal implants · Business Updates
  2. Jaykay Enterprises grants 13,000 stock options to employees · Capital Market Events
  3. Jaykay Enterprises to lend up to Rs 100 Cr to wholly owned subsidiary JK Defence · Credit & Debt
All filings ↓
Ask Nexa about JAYKAY ENTERPRISES LTD

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Operates across defence and aerospace, digital services, digital manufacturing, and medical implants. The Defence & Aerospace Division takes orders from strategic organisations including BrahMos, HAL, BEL, BDL, NSTL and ADA, and added precision manufacturing capability via the April 2026 acquisition of Patange Industries. The Digital Service arm runs the JIVA AI platform, deployed in US and European markets. A medical implants business received CDSCO certification and began commercial production of patient-specific implants. On a standalone basis for FY26, Defence & Aerospace contributed 18.0% of segment revenue, Digital Manufacturing and Advance Systems 0.3%, with Unallocated/Residual at 81.7%. Manufacturing facilities include an expanded Cherlapally plant in Hyderabad and a Devanahalli facility under progress. Employee cost is the largest expense at 59.9% of revenue (Rs 143.57 crore); materials are 6.5% (Rs 15.61 crore).

Revenue mix · reported segments
Unallocated/ Residual Segment81.7%
Defence & Aerospace Division18.0%
Digital Manufacturing and Advance Systems0.3%
Operating scale
Defence customers
BrahMos, HAL, BEL, BDL, NSTL, ADA
Cherlapally facility
Expansion completed (Hyderabad)
Devanahalli manufacturing plant
Under progress
Patange Industries acquisition
Completed April 2026 for precision manufacturing
JIVA AI platform
Deployed in US and European markets
Patient-specific implants
CDSCO certified, commercial production commenced
Who pays it
Defence organisations (BrahMos, HAL, BEL, BDL, NSTL, ADA), medical implant users, AI platform users in US/Europe
Biggest cost
Employee cost at Rs 143.57 crore (59.9% of revenue)
Kind of business
Diversified industrial/technology company spanning defence, digital services, and medical implants
Where it sits
Listed Aerospace & Defense classified entity (Capital Goods sector) on NSE and BSE
Market Cap
₹2,624 Cr
P / E (TTM)
12.8×
EV / EBITDA
11.4×
Div Yield
—
Growth
278.6%▲
Revenue 5y CAGR
PAT +52.6% · EBITDA +71.7%
Quality
6.3%·
ROCE (5y median)
ROE 5.5% (5y median) · margin 101.8%
Leverage
0.01·
Debt / Equity · low
Net cash ₹21 Cr
Revenue FY21→FY26
778.1×▲
Margin −8358.4 pts
₹0 Cr → ₹240 Cr
Cash conversion
-0.11×▼
Operating cash ÷ profit · 5 yrs
₹-29 Cr on ₹258 Cr
Moves on a normal day
2.03%·
Median daily move
Last 221 sessions · the yardstick for filing-day moves
Where it sits among 25 Aerospace & Defense peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#1/23
P/B#2/23
ROCE#4/26
ROE#1/23
Debt / Equity#11/23
EBITDA margin#15/23
Revenue growth#10/23
Profit growth#18/21

Scorecard

Measured from the filed financials, judged against its Aerospace & Defense peers · as of FY26 — not investment advice

Strengths
Revenue compounding 279% a year over 5 years
Profit compounding 53% a year over 5 years
Concerns
Erratic profits — up in only 2 of the last 5 years
Returns on capital 6.3% (5-year median)
#4 of 26 in Aerospace & Defense on the latest reported figures · up from 16.4% in FY21
Over 5 years it reported ₹258 Cr of profit and an operating cash outflow of ₹29 Cr — -0.11×
Less than 60p of every ₹1 of profit arrived as cash
Heavy working capital — 161 days of cash tied up
EPS grew slower than profit — the share count rose (bonus or dilution)

Charts

How has the market priced it — with filings on the timeline?

JAYKAY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from JAYKAY ENTERPRISES LTD's filed financials and exchange disclosures

What does JAYKAY ENTERPRISES LTD do?

JAYKAY ENTERPRISES LTD is a Aerospace & Defense company listed on NSE and BSE, trading under the symbol JAYKAY.

Is JAYKAY ENTERPRISES LTD profitable?

Yes. Over the trailing twelve months JAYKAY ENTERPRISES LTD reported a net profit of ₹200 Cr on revenue of ₹259 Cr.

Does JAYKAY ENTERPRISES LTD pay a dividend?

Not in the latest reported year — JAYKAY ENTERPRISES LTD's dividend payout for FY26 was nil.

Is JAYKAY ENTERPRISES LTD debt-free?

On a net basis, yes. It reported borrowings of ₹7.92 Cr on its 31 Mar 2026 balance sheet, but holds ₹21 Cr more cash than debt.

Is JAYKAY ENTERPRISES LTD expensive compared with its peers?

On trailing P/E, JAYKAY ENTERPRISES LTD ranks 1 of 23 in Aerospace & Defense — cheaper than 100% of them, against an industry median of 69.8×. This is a position, not a valuation judgement.

How much does the JAYKAY ENTERPRISES LTD share price move in a day?

On a typical session JAYKAY ENTERPRISES LTD moves 2.03% — that is the median absolute close-to-close move across its last 221 trading days. MarketPing measures each filing's price reaction against it.

Where can I track JAYKAY ENTERPRISES LTD's announcements?

Every NSE and BSE filing by JAYKAY ENTERPRISES LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.